002393.SZ
力生制药
SZSE · Healthcare · C 制造业 · CN
CNY 13.82
−4.16%Margins
Gross margin
54.5%
EBITDA margin
40.2%
EBIT margin
34.3%
Net margin
30.5%
FCF margin
15.9%
9.0%
Return on equity
7.5%
Return on assets
10.0%
Return on invested capital
0.24x
Asset turnover
CNY 249.5M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026